O
OGN
OGN34 segments tracked|5 years of data|Annual (10-K)
Total Revenue
$3.8B40.7%
FY2025
Operating Segments
34Active segments
Blended Margin
0.0%Operating margin
Highest Margin
0.0%Nexplanon Implanon NXT
Segment Shift
Nexplanon Implanon NXT has grown from 13.4% to 25.4% of total revenue since FY2021, with 0.0% operating margins.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2025
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Nexplanon Implanon NXT | $963M | $0 | 0.0% | 25.4% | +0.0% |
| Atozet | $473M | $0 | 0.0% | 12.5% | +0.0% |
| Singulair | $359M | $0 | 0.0% | 9.5% | +0.0% |
| Other Sundry Established Brands | $328M | $0 | 0.0% | 8.6% | +0.0% |
| Zetia | $317M | $0 | 0.0% | 8.3% | +0.0% |
| Other Non Opioid Pain Bone And Dermatology | $295M | $0 | 0.0% | 7.8% | +0.0% |
| Nasonex | $276M | $0 | 0.0% | 7.3% | +0.0% |
| Renflexis | $274M | $0 | 0.0% | 7.2% | +0.0% |
| Arcoxia | $270M | $0 | 0.0% | 7.1% | +0.0% |
| Cozaar Hyzaar | $243M | $0 | 0.0% | 6.4% | +0.0% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free